Project grants accelerate research advancements
Since 2011, Pancare has delivered over $2 million toward Australian cancer research programs, aiming to accelerate advancements and innovation that help improve outcomes and quality of life for Australians impacted by upper gastrointestinal (GI) cancer – pancreatic, liver, stomach, biliary and oesophageal cancers.
Our aim of doubling the survival rates from upper gastrointestinal cancers will be achieved through the establishment of partnerships and collaborative frameworks that deliver research outcomes in these six key priority areas:
- Discovery of new treatments for upper gastrointestinal cancers
- Early detection of upper gastrointestinal cancers
- Personalised medicine strategies to help those with upper gastrointestinal cancers
- Optimal patient care for those with upper gastrointestinal cancers
- Support and development of future leaders
- Acceleration of clinical trials for upper gastrointestinal cancers.
Pancare Foundation Project Grants are awarded at various times for projects of high quality requiring short-term funding. This short-term funding will help accelerate projects to maximise chances of obtaining future government grants.
In 2021, we are refreshing our Pancare Foundation Project Grants program in line with our fundraising efforts to deliver even more research programs across all five areas of upper gastronintestinal cancers.
Learn more:
> Head to our homepage and sign up to our newsletter to receive notifications regarding grant round timelines.
> Learn more about our Clinical Research Programs
Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme
Pancare continues to be a proud partner with Cancer Australia in their Priority-driven Collaborative Cancer Research Scheme (PdCCRS). The PdCCRS is an annual national research project grants scheme that funds cancer research in identified priority areas to help reduce the impact of cancer in the community and improve outcomes for people affected by cancer.
Through its partnership approach, the PdCCRS brings together funders of cancer research to coordinate funding of priority-driven cancer research at the national level and maximise cancer research investment across Australia. The Scheme is also designed to foster collaboration between cancer researchers to build Australia’s cancer research capacity, and encourage consumer participation in cancer research, from design to implementation.
This PdCCRS research scheme is managed by Cancer Australia, and the agency collaborates with the National Health and Medical Research Council (NHMRC) to facilitate registration and initial assessment of NHMRC grant applications and endorse grants funded through this scheme in recognition of their scientific merit.
Each year, Cancer Australia and its funding partners, including Pancare, identify research priorities – areas of research with the greatest need and the potential for high-impact research. The collaboratively discerned priorities are announced prior to the grant round opening. More information about annual funding priorities, application submission deadlines and specific requirements can be found on the Cancer Australia website.
Pancare will announce its PdCCRS partnerships in its regular newsletters and social media.
Learn more:
> Cancer Australia – Priority Driven Research
Help fund research that seeks to discover new and specialised treatments for upper gastrointestinal cancers.
